Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Identification of Differentially Expressed and Spliced Genes with RNA Sequencing Analysis of CLL Specimens

Wei Liao, MS, Gwen Jordaan, MS, Artur Jaroszewicz, Matteo Pellegrini, Sanjai Sharma, MD, MB, BS

Blood (2012) 120 (21): 4582.

https://doi.org/10.1182/blood.V120.21.4582.4582

Published: 2012

Journal Articles

Rasgrf1 Overexpression Amplifies B Cell Receptor Signaling in Chronic Lymphocytic Leukemia Specimens

Wei Liao, MS, Gwen Jordaan, MS, Sanjai Sharma, MD, MB, BS

Blood (2012) 120 (21): 926.

https://doi.org/10.1182/blood.V120.21.926.926

Published: 2012

Journal Articles

Rictor Overexpression and mTORC2 Signaling in Chronic Lymphocytic Leukemia

Gwen Jordaan, MS, Wei Liao, MS, Joe Gera, Ph.D, Sanjai Sharma, MD, MB, BS

Blood (2012) 120 (21): 3884.

https://doi.org/10.1182/blood.V120.21.3884.3884

Published: 2012

Journal Articles

Correction of Aberrant E-Cadherin Splicing with HDAC Inhibitors in CLL

Gwen Jordaan, MS, Wei Liao, MS, Sanjai Sharma, MD, MB, BS

Blood (2011) 118 (21): 1776.

https://doi.org/10.1182/blood.V118.21.1776.1776

Published: 2011

Journal Articles

Overexpression of Rasgrf1, a Guanine Nucleotide Exchange Factor in Chronic Lymphocytic Leukemia.

Sanjai Sharma, MD, MB, BS

Blood (2009) 114 (22): 1253.

https://doi.org/10.1182/blood.V114.22.1253.1253

Published: 2009

Journal Articles

Aberrant splicing of the E-cadherin transcript is a novel mechanism of gene silencing in chronic lymphocytic leukemia cells

Sanjai Sharma, Alan Lichtenstein

Blood (2009) 114 (19): 4179–4185.

https://doi.org/10.1182/blood-2009-03-206482

Published: 2009

Includes: Supplemental data

Journal Articles

Aberrant Splicing of the E-Cadherin Gene Is a Novel Mechanism of Gene Silencing in Chronic Lymphocytic Leukemia Cells

Sanjai Sharma, MD, MB, BS, Alan Lichtenstein, MD

Blood (2008) 112 (11): 2842.

https://doi.org/10.1182/blood.V112.11.2842.2842

Published: 2008

Journal Articles

Dexamethasone-induced apoptotic mechanisms in myeloma cells investigated by analysis of mutant glucocorticoid receptors

Sanjai Sharma, Alan Lichtenstein

Blood (2008) 112 (4): 1338–1345.

https://doi.org/10.1182/blood-2007-11-124156

Published: 2008

Journal Articles

Dexamethasone Induced Apoptotic Mechanisms in Myeloma Cells by Analysis of Mutant Glucocorticoid Receptors.

Sanjai Sharma, MD, Alan Lichtenstein, MD

Blood (2007) 110 (11): 2492.

https://doi.org/10.1182/blood.V110.11.2492.2492

Published: 2007

Journal Articles

Hepcidin Overproduction Mediates the Anemia of Multiple Myeloma.

Sanjai Sharma, MD, Elizabeta Nemeth, Ph.D, Yi-Hsiang Chen, MD, Alissa Huston, MD, G.D. Roodman, MD, Julia Goodnough, Tomas Ganz, MD, Alan Lichtenstein, MD

Blood (2006) 108 (11): 516.

https://doi.org/10.1182/blood.V108.11.516.516

Published: 2006

Journal Articles

AKT Kinase Addiction in Multiple Myeloma.

Carolyne Bardeleben, PhD, Huajun Yan, PhD, Patrick Frost, PhD, Bao Hoang, PhD, Yijiang Shi, MD, PhD, Sanjai Sharma, MD, Alan Lichtenstein, MD

Blood (2006) 108 (11): 3431.

https://doi.org/10.1182/blood.V108.11.3431.3431

Published: 2006

Journal Articles

Oncogenic RAS mutations in myeloma cells selectively induce cox-2 expression, which participates in enhanced adhesion to fibronectin and chemoresistance

Bao Hoang, Li Zhu, Yijiang Shi, Patrick Frost, Huajun Yan, Sanjai Sharma, Sherven Sharma, Lee Goodglick, Steven Dubinett, Alan Lichtenstein

Blood (2006) 107 (11): 4484–4490.

https://doi.org/10.1182/blood-2005-09-3926

Published: 2006

Journal Articles

Premature Termination Codon Mutations in Chronic Lymphocytic Leukemia (CLL): Identification of Potential Tumor Suppressors in CLL Including E-Cadherin.

Sanjai Sharma, MD, Alan Lichtenstein, MD

Blood (2005) 106 (11): 2935.

https://doi.org/10.1182/blood.V106.11.2935.2935

Published: 2005

Journal Articles

Mechanism by Which mTOR Inhibitors Sesitize Multiple Myeloma Cells to Dexamethasone-Induced Apoptosis.

Huajun Yan, PhD, Patrick Frost, PhD, Yijiang Shi, MD & PhD, Bao Hoang, PhD, Sanjai Sharma, MD, Myrna Fisher, Joseph Gera, PhD, Alan Lichtenstein, MD

Blood (2005) 106 (11): 1582.

https://doi.org/10.1182/blood.V106.11.1582.1582

Published: 2005

NARROW

Identification of Differentially Expressed and Spliced Genes with RNA Sequencing Analysis of CLL Specimens

Rasgrf1 Overexpression Amplifies B Cell Receptor Signaling in Chronic Lymphocytic Leukemia Specimens

Rictor Overexpression and mTORC2 Signaling in Chronic Lymphocytic Leukemia

Correction of Aberrant E-Cadherin Splicing with HDAC Inhibitors in CLL

Overexpression of Rasgrf1, a Guanine Nucleotide Exchange Factor in Chronic Lymphocytic Leukemia.

Aberrant splicing of the E-cadherin transcript is a novel mechanism of gene silencing in chronic lymphocytic leukemia cells

Aberrant Splicing of the E-Cadherin Gene Is a Novel Mechanism of Gene Silencing in Chronic Lymphocytic Leukemia Cells

Dexamethasone-induced apoptotic mechanisms in myeloma cells investigated by analysis of mutant glucocorticoid receptors

Dexamethasone Induced Apoptotic Mechanisms in Myeloma Cells by Analysis of Mutant Glucocorticoid Receptors.

Hepcidin Overproduction Mediates the Anemia of Multiple Myeloma.

AKT Kinase Addiction in Multiple Myeloma.

Oncogenic RAS mutations in myeloma cells selectively induce cox-2 expression, which participates in enhanced adhesion to fibronectin and chemoresistance

Premature Termination Codon Mutations in Chronic Lymphocytic Leukemia (CLL): Identification of Potential Tumor Suppressors in CLL Including E-Cadherin.

Mechanism by Which mTOR Inhibitors Sesitize Multiple Myeloma Cells to Dexamethasone-Induced Apoptosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only